US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.940
  • +0.090+3.16%
Close Apr 26 16:00 ET
  • 2.970
  • +0.030+1.01%
Post 19:31 ET
359.74MMarket Cap-1986P/E (TTM)

Mersana Therapeutics Key Stats

Mersana Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 28, 2024

Revenue(YoY)

10.70M

-27.14%
EPS(YoY)

-0.16

+63.64%

Strong Buy

Mar 31, 2024

Mersana Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 8.708M--
--2024/Q1-- / 8.503M--
Feb 28, 20242023/Q410.701M / 14.772M--
Nov 7, 20232023/Q37.698M / 9.344M--
--2023/Q210.654M / 12.955M--
May 9, 20232023/Q17.802M / 18.286M--
Feb 28, 20232022/Q414.688M / 13.671M--
Nov 7, 20222022/Q35.573M / 56.783M--
Aug 8, 20222022/Q24.284M / 2.202M--
May 9, 20222022/Q12.036M / 17.240M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 8.708M--
--2024/Q1-- / 8.503M--
Feb 28, 20242023/Q410.701M / 14.772M--
Nov 7, 20232023/Q37.698M / 9.344M--
--2023/Q210.654M / 12.955M--
May 9, 20232023/Q17.802M / 18.286M--
Feb 28, 20232022/Q414.688M / 13.671M--
Nov 7, 20222022/Q35.573M / 56.783M--
Aug 8, 20222022/Q24.284M / 2.202M--
May 9, 20222022/Q12.036M / 17.240M--

Unlock Free Earnings Estimates

Mersana Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg